Anomaly Detection and Artifact Recovery in PET Attenuation-Correction Images Using the Likelihood Function

di Laymon, Charles M., Bowsher, James E.
Pubblicazione 2013

Nuclear Imaging of a Pregnant Patient: Should We Perform Nuclear Medicine Procedures During Pregnancy?

di Bural, Gonca G., Laymon, Charles M., Mountz, James M.
Pubblicazione 2012

Distinguishing Pseudoprogression From Progression in High-Grade Gliomas: A Brief Review of Current Clinical Practice and Demonstration of the Potential Value of (18)F-FDG PET

di Oborski, Matthew J., Laymon, Charles M., Lieberman, Frank S., Mountz, James M.
Pubblicazione 2013

PET/CT Artifacts

di Blodgett, Todd M., Mehta, Ajeet S., Mehta, Amar S., Laymon, Charles M., Carney, Jonathan, Townsend, David W.
Pubblicato in Clin Imaging (2011)

[(18)F]ML-10 PET: Initial Experience in Glioblastoma Multiforme Therapy Response Assessment

di Oborski, Matthew J., Laymon, Charles M., Lieberman, Frank S., Qian, Yongxian, Drappatz, Jan, Mountz, James M.
Pubblicato in Tomography (2016)

First use of (18)F-labeled ML-10 PET to assess apoptosis change in a newly diagnosed glioblastoma multiforme patient before and early after therapy

di Oborski, Matthew J, Laymon, Charles M, Lieberman, Frank S, Drappatz, Jan, Hamilton, Ronald L, Mountz, James M
Pubblicazione 2014

Challenges and Approaches to Quantitative Therapy Response Assessment in Glioblastoma Multiforme Using the Novel Apoptosis Positron Emission Tomography Tracer F-18 ML-10

di Oborski, Matthew J, Laymon, Charles M, Qian, Yongxian, Lieberman, Frank S, Nelson, Arden D, Mountz, James M
Pubblicazione 2014

Inter-operator variability in compartmental kinetic analysis of (18)F-fluoromisonidazole dynamic PET

di Nehmeh, Sadek A., Schwartz, Jazmin, Grkovski, Milan, Yeung, Ivan, Laymon, Charles M., Muzi, Mark, Humm, John L.
Pubblicato in Clin Imaging (2018)

Short-T(2) Imaging for Quantifying Concentration of Sodium ((23)Na) of Bi-Exponential T(2) Relaxation

di Qian, Yongxian, Panigrahy, Ashok, Laymon, Charles M., Lee, Vincent K., Drappatz, Jan, Lieberman, Frank S., Boada, Fernando E., Mountz, James M.
Pubblicato in Magn Reson Med (2014)

Characterization of point-spread function specification error on Geometric Transfer Matrix partial volume correction in [(11)C]PiB amyloid imaging

di Laymon, Charles M., Minhas, Davneet S., Royse, Sarah K., Aizenstein, Howard J., Cohen, Ann D., Tudorascu, Dana L., Klunk, William E.
Pubblicato in EJNMMI Phys (2021)

Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis

di Laymon, Charles M., Oborski, Matthew J., Lee, Vincent K., Davis, Denise K., Wiener, Erik C., Lieberman, Frank S., Boada, Fernando E., Mountz, James M.
Pubblicazione 2012

Combined VLA-4–Targeted Radionuclide Therapy and Immunotherapy in a Mouse Model of Melanoma

di Choi, Jaeyeon, Beaino, Wissam, Fecek, Ronald J., Fabian, Kellsye P.L., Laymon, Charles M., Kurland, Brenda F., Storkus, Walter J., Anderson, Carolyn J.
Pubblicato in J Nucl Med (2018)

Human Biodistribution and Dosimetry of the D(2/3) Agonist (11)C-N-Propylnorapomorphine ((11)C-NPA) Determined from PET

di Laymon, Charles M., Mason, N. Scott, Frankle, W. Gordon, Carney, Jonathan P., Lopresti, Brian J., Litschge, Maralee Y., Mathis, Chester A., Mountz, James M., Narendran, Rajesh
Pubblicazione 2009

A Comparative Evaluation of the Dopamine D(2/3) Agonist Radiotracer [(11)C](−)-N-Propyl-norapomorphine and Antagonist [(11)C]Raclopride to Measure Amphetamine-Induced Dopamine Rele...

di Narendran, Rajesh, Mason, N. Scott, Laymon, Charles M., Lopresti, Brian J., Velasquez, Natalie D., May, Maureen A., Kendro, Steve, Martinez, Diana, Mathis, Chester A., Frankle, W. Gordon
Pubblicazione 2010

Inter-rater reliability of manual and automated region-of-interest delineation for PiB PET

di Rosario, Bedda L., Weissfeld, Lisa A., Laymon, Charles M., Mathis, Chester A., Klunk, William E., Berginc, Michael D., James, Jeffrey A., Hoge, Jessica A., Price, Julie C.
Pubblicazione 2010

Comparison of qualitative and quantitative imaging characteristics of [(11)C]PiB and [(18)F]flutemetamol in normal control and Alzheimer's subjects

di Mountz, James M., Laymon, Charles M., Cohen, Ann D., Zhang, Zheng, Price, Julie C., Boudhar, Sanaa, McDade, Eric, Aizenstein, Howard J., Klunk, William E., Mathis, Chester A.
Pubblicato in Neuroimage Clin (2015)

Relative (11)C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session (15)O-Water and (11)C-PiB PET

di Chen, Yin J., Rosario, Bedda L., Mowrey, Wenzhu, Laymon, Charles M., Lu, Xueling, Lopez, Oscar L., Klunk, William E., Lopresti, Brian J., Mathis, Chester A., Price, Julie C.
Pubblicato in J Nucl Med (2015)

Cognitive indicators of transition to preclinical and prodromal stages of Alzheimer's disease in Down syndrome

di Hartley, Sigan L., Handen, Benjamin L., Devenny, Darlynne, Tudorascu, Dana, Piro‐Gambetti, Brianna, Zammit, Matthew D., Laymon, Charles M., Klunk, William E., Zaman, Shahid, Cohen, Annie, Christian, Bradley T.
Pubblicato in Alzheimers Dement (Amst) (2020)

PET Imaging of D(2/3) agonist binding in healthy human subjects with the radiotracer [(11)C]-N-propyl-nor-apomorphine (NPA): preliminary evaluation and reproducibility studies

di Narendran, Rajesh, Frankle, W. Gordon, Mason, N. Scott, Laymon, Charles M., Lopresti, Brian J, Price, Julie C., Kendro, Steve, Vora, Shivangi, Litschge, Maralee, Mountz, James M., Mathis, Chester A.
Pubblicazione 2009

First report of (68)Ga-PRGD2 PET/MRI molecular imaging of vaso-occlusion in a patient with sickle cell disease

di Novelli, Enrico M, Moon, Chan Hong, Pham, Tiffany A, Perkins, Lydia A, Little-Ihrig, Lynda, Tavakoli, Sina, Mason, N. Scott, Lang, Lixin, Chen, Xiaoyuan, Laymon, Charles M, Gladwin, Mark T, Anderson, Carolyn J
Pubblicato in BJR Case Rep (2020)